Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.800
-0.010 (-0.55%)
At close: Dec 20, 2024, 4:00 PM
1.839
+0.039 (2.18%)
After-hours: Dec 20, 2024, 7:02 PM EST
Caribou Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -148.12 | -102.07 | -99.42 | -66.92 | -34.31 | -23.43 |
| Depreciation & Amortization | 3.48 | 3.53 | 1.62 | 0.98 | 0.9 | 0.75 |
| Loss (Gain) From Sale of Assets | 0 | -0.03 | - | 0 | 0.07 | 0 |
| Asset Writedown & Restructuring Costs | 1.63 | - | 0.6 | 1 | 3.13 | - |
| Loss (Gain) From Sale of Investments | -1.97 | -4.42 | -0.66 | 0.05 | 0.73 | -2.29 |
| Stock-Based Compensation | 16.35 | 13.75 | 11.72 | 3.45 | 1 | 1.23 |
| Other Operating Activities | 0.3 | 3.28 | -0.62 | -0.15 | -4.92 | - |
| Change in Accounts Receivable | 1.81 | 0.88 | 0.19 | -1.16 | -0.64 | -0.22 |
| Change in Accounts Payable | 0.61 | 1.82 | -2.72 | 1.14 | 0.04 | 1.18 |
| Change in Unearned Revenue | -2.78 | -16.94 | -4.84 | 29.64 | -0.61 | -0.8 |
| Change in Other Net Operating Assets | 4.4 | 6.75 | 3.26 | -0.87 | 1.87 | -1.31 |
| Operating Cash Flow | -124.11 | -93.29 | -90.97 | -32.52 | -33.22 | -32.01 |
| Capital Expenditures | -6.64 | -11.61 | -6.45 | -2.12 | -0.32 | -0.88 |
| Sale of Property, Plant & Equipment | - | - | - | - | 0.01 | - |
| Sale (Purchase) of Intangibles | -1.63 | - | -0.6 | -1 | -1 | - |
| Investment in Securities | 47.47 | -56.57 | -86.2 | -173.28 | 7.67 | 28.12 |
| Investing Cash Flow | 39.2 | -68.18 | -93.25 | -176.4 | 6.36 | 27.23 |
| Long-Term Debt Issued | - | - | - | 1.15 | 1.58 | - |
| Long-Term Debt Repaid | - | - | - | -0.12 | -0.11 | -0.05 |
| Net Debt Issued (Repaid) | - | - | - | 1.03 | 1.47 | -0.05 |
| Issuance of Common Stock | 12.82 | 154.3 | 2.13 | 323.57 | 0.27 | 0.22 |
| Financing Cash Flow | 12.82 | 154.3 | 2.13 | 433.43 | 1.74 | 0.17 |
| Net Cash Flow | -72.09 | -7.18 | -182.08 | 224.51 | -25.12 | -4.6 |
| Free Cash Flow | -130.75 | -104.9 | -97.42 | -34.64 | -33.53 | -32.89 |
| Free Cash Flow Margin | -1139.42% | -304.27% | -703.34% | -360.91% | -271.27% | -568.24% |
| Free Cash Flow Per Share | -1.46 | -1.42 | -1.60 | -1.09 | -3.92 | -3.93 |
| Cash Income Tax Paid | - | 0.17 | - | 0.01 | 0.02 | 1.81 |
| Levered Free Cash Flow | -78.73 | -64.36 | -56.11 | -33.46 | -21.16 | - |
| Unlevered Free Cash Flow | -78.73 | -64.36 | -56.11 | -33.46 | -21.15 | - |
| Change in Net Working Capital | -10.51 | -2.51 | -4.11 | -7.09 | -0.84 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.